{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:04:23Z","timestamp":1782781463318,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jhepr.2023.100958","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:54:22Z","timestamp":1699019662000},"page":"100958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-108X","authenticated-orcid":false,"given":"Omar A.","family":"Saldarriaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Wanninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4996-1094","authenticated-orcid":false,"given":"Esteban","family":"Arroyave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2311-6028","authenticated-orcid":false,"given":"Joseph","family":"Gosnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhoshi","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Oneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3913-0609","authenticated-orcid":false,"given":"Daniel","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Millian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2509-0877","authenticated-orcid":false,"given":"Michael L.","family":"Kueht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshata","family":"Moghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica I.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Spratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2054-684X","authenticated-orcid":false,"given":"Laura","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared K.","family":"Burks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-7621","authenticated-orcid":false,"given":"Heather L.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100958_bib1","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100958_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/14728222.2022.2132145","article-title":"Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease","volume":"26","author":"Laursen","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jhepr.2023.100958_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2023.100958_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31108","article-title":"Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study","volume":"72","author":"Ratziu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/HEP.0000000000000270","article-title":"Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression","volume":"78","author":"Guillot","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100958_bib10","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2023.100958_bib11","first-page":"25","article-title":"Increase of infiltrating monocytes in the livers of patients with chronic liver diseases","volume":"21","author":"Huang","year":"2016","journal-title":"Discov Med"},{"key":"10.1016\/j.jhepr.2023.100958_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/hep.25657","article-title":"Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans","volume":"56","author":"Antoniades","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib13","article-title":"Activated hepatic stellate cells induce infiltration and formation of CD163(+) macrophages via CCL2\/CCR2 pathway","volume":"8","author":"Xi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhepr.2023.100958_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40169-015-0047-4","article-title":"The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases","volume":"4","author":"Wermuth","year":"2015","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jhepr.2023.100958_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.26016","article-title":"Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics","volume":"57","author":"Liaskou","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/CEG.S248635","article-title":"Changes in function and dynamics in hepatic and splenic macrophages in non-alcoholic fatty liver disease","volume":"13","author":"Fukushima","year":"2020","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100958_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100315","article-title":"Horizon scanning of therapeutic modalities for nonalcoholic steatohepatitis","volume":"24","author":"Patikorn","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2023.100958_bib18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/apt.13816","article-title":"GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis","volume":"44","author":"Harrison","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100958_bib19","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A\u00a0randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cct.2016.02.012","article-title":"Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design","volume":"47","author":"Friedman","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jhepr.2023.100958_bib21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/hep4.1494","article-title":"Multispectral imaging enables characterization of intrahepatic macrophages in patients with chronic liver disease","volume":"4","author":"Saldarriaga","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100958_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib23","first-page":"270","article-title":"Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues [Cancer Genetics 268-269 (2022) 137-143]","volume":"31","author":"Zheng","year":"2023","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jhepr.2023.100958_bib24","series-title":"Uniform manifold approximation and projection for dimension reduction","author":"McInnes","year":"2018"},{"key":"10.1016\/j.jhepr.2023.100958_bib25","series-title":"Uniform manifold approximation and projection (UMAP)","author":"Meehan","year":"2021"},{"key":"10.1016\/j.jhepr.2023.100958_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15095","article-title":"Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer","volume":"8","author":"Carstens","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2023.100958_bib27","series-title":"Spatial point patterns: methodology and applications with R","author":"Baddeley","year":"2015"},{"key":"10.1016\/j.jhepr.2023.100958_bib28","series-title":"A\u00a0language and environment for statistical computing","author":"Team","year":"2014"},{"key":"10.1016\/j.jhepr.2023.100958_bib29","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2009"},{"key":"10.1016\/j.jhepr.2023.100958_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2019.105922","article-title":"Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design","volume":"89","author":"Anstee","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jhepr.2023.100958_bib31","article-title":"Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators","volume":"4","author":"Pastore","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100958_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gtc.2019.10.001","article-title":"Why do lifestyle recommendations fail in most patients with nonalcoholic fatty liver disease?","volume":"49","author":"Hernandez Roman","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jhepr.2023.100958_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0041-1729971","article-title":"Dietary treatment for NAFLD: new clinical and epidemiological evidence and updated recommendations","volume":"41","author":"Zelber-Sagi","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100958_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.22952","article-title":"CCR2 promotes hepatic fibrosis in mice","volume":"50","author":"Seki","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib35","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1172\/JCI41732","article-title":"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice","volume":"120","author":"Berres","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100958_bib36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/liv.12050","article-title":"Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C","volume":"33","author":"Gadd","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100958_bib37","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.3390\/cells11213387","article-title":"Multiplexed digital\u00a0spatial protein profiling reveals distinct phenotypes of mononuclear phagocytes in livers with advanced fibrosis","volume":"11","author":"Lee","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jhepr.2023.100958_bib38","article-title":"Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease","volume":"5","author":"Jiao","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100958_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.892250","article-title":"Multi-scale spatial analysis of the\u00a0tumor microenvironment reveals features of cabozantinib and nivolumab efficacy in hepatocellular carcinoma","volume":"13","author":"Mi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100958_bib40","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100958_bib41","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1136\/gutjnl-2021-326350","article-title":"PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma","volume":"71","author":"Lu","year":"2022","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jhepr.2023.100958_bib42","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100958_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature13992","article-title":"A\u00a0comparative encyclopedia of DNA elements in the mouse genome","volume":"515","author":"Yue","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2023.100958_bib44","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3390\/cells9122566","article-title":"Comparative transcriptomics analyses in livers of mice, humans, and humanized mice define human-specific gene networks","volume":"9","author":"Jiang","year":"2020","journal-title":"Cells"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T09:59:39Z","timestamp":1716285579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923002896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2589555923002896"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100958","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100958"}}